Dr Reddy's Laboratories Hits Day Low Amid Price Pressure, Falls to Rs 1242.75

Dr Reddys Laboratories has experienced a notable decline today, with the stock down by 3.84% as of October 29, 2025. The stock reached an intraday low of Rs 1242.75, reflecting a decrease of 3.7%. This downturn comes after a brief period of three consecutive days of gains, indicating a potential trend reversal. In terms of performance metrics, Dr Reddys Laboratories has underperformed compared to the broader market, with a 1-day performance of -3.74% against the Sensex's gain of 0.40%. Over the past week, the stock has also lagged, showing a decline of 3.67% while the Sensex rose by 0.64%. Looking at longer-term performance, Dr Reddys Laboratories has faced challenges, with a year-to-date decline of 10.52%, contrasting sharply with the Sensex's increase of 8.74%. The stock's moving averages indicate that it is currently above its 200-day moving average but below its shorter-term moving averages, suggesting mixed signals in its recent performance trajectory.